Written by Vered Smith, Science Writer Researchers have published a paper revealing genetic variants associated with the development of life-threatening […]
The team behind a new study has found that many pathogenic genetic variants have a low risk of causing disease. […]
Numerous genetic variants in the human genome have been linked to type 2 diabetes. However, as most of these variants […]
Recently, a genome-wide association study has identified genetic variants that influence white matter microstructure in the brain. White matter was […]
Researchers have harnessed the power of genome-wide sequencing and functional profiling of immune cells to understand how genetic variants can […]
A study published in Scientific Reports, has identified six significant oral cancer associated genes through differential analysis. Oral cancer Oral […]
A recent study published in the Journal of the National Cancer Institute has discovered three genetic variants linked to an […]
Heart disease is one of the leading causes of death globally. Two of the most common forms of heart disease […]
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
Written by Isobel Young, Science Writer By the end of 2018, Genomics England had completed their 100,000 Genome Project (100KGP), […]